The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome

Not Applicable

• Conditions: Covid19

• Registration Number: NCT04983394
• Lead Sponsor: Cumhuriyet University

Brief Summary

The aim of this study is to investigate the effectiveness of virtual reality exercises on pain, cardiopulmonary capacity, mood and quality of life in patients with post-COVID syndrome.

Detailed Description

This study, which will be conducted in Sivas Cumhuriyet University, Physical Medicine and Rehabilitation Clinic, was diagnosed with COVID-19 from an oropharyngeal or nasopharyngeal swab sample more than 90 days ago with polymerase chain reaction, whose symptoms have continued since the diagnosis of COVID-19, and inpatient treatment. 63 adult female and male post-COVID syndrome patients who did not develop pneumonia or organ failure findings will be included. Those who have had acute myocardial infarction in the last 6 months, have cardiovascular system disease such as uncontrolled hypertension, arrhythmia, aneurysm, cardiac failure, have undergone fracture or orthopedic surgery in the last 3 months, have a known chronic respiratory system disease, cause widespread pain such as fibromyalgia syndrome Those who have a disease or cannot be mobilized independently will not be included in the study. The sample size was determined as d=0.80 α=0.05 p=0.80410 n=54 using the G\*Power 3.1.9.4 program. Considering the 15% drop-out risk, 63 patients were planned to be included.

Demographic data of all participants, including age, gender, height, weight and body mass index, and the time elapsed since the diagnosis of COVID-19 will be recorded. In addition, participants' pain intensity, functional capacity, general health status, mood, and fatigue levels will be evaluated.

Study Timeline

• Study First Submitted: 2021-07-28
• Study First Submitted QC: 2021-07-29
• Study First Posted: 2021-07-30
• Study Start: 2021-08-01
• Primary Completion: 2022-01-30
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-07
• Last Update Posted: 2022-03-09
• Study Completion: 2022-05-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

• diagnosed with COVID-19 by polymerase chain reaction from an oropharyngeal or nasopharyngeal swab sample more than 90 days ago, whose symptoms have continued since the diagnosis of COVID-19

Exclusion Criteria

• have been hospitalized due to COVID-19,
• have developed pneumonia or organ failure findings.
• have had an acute myocardial infarction in the last 6 months,
• have cardiovascular system disease such as uncontrolled hypertension, arrhythmia, aneurysm, cardiac failure,
• have undergone fracture or orthopedic surgery in the last 3 months,
• have a known chronic respiratory system disease,
• have widespread pain such as fibromyalgia syndrome

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
visual Analogue Scale	8th week

Secondary Outcome Measures

Name	Time	Method
hospital anxiety and depression scale-Anxiety	0th and 8th week
Fatigue severity scale	0th and 8th week
6 minutes walking test	0th and 8th week
hospital anxiety and depression scale-Depression	0th and 8th week
Short Form-12	0th and 8th week

Trial Locations

Locations (1)

Sivas Cumhuriyet University; 🇹🇷 Sivas, Turkey